Cislini Jeff 4
4 · Revolution Medicines, Inc. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Cislini Jeff
General Counsel
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-11-18−13,388→ 0 totalExercise: $42.45From: 2025-03-04Exp: 2031-03-03→ Common Stock (13,388 underlying) - Sale
Common Stock
2025-11-18$70.14/sh−13,388$939,008→ 50,425 total - Exercise/Conversion
Common Stock
2025-11-18$42.45/sh+13,388$568,321→ 63,813 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.
- [F2]Includes 43,910 restricted stock units.
- [F3]This transaction was executed in multiple trades in prices ranging from $70.00 to $70.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.